Theralase Technologies Inc. V.TLT

Volume

[Camphikefish]

Is it that no one wants to hit the ask, lack of shares for sale, or something we do not know, any combination, or all of the above? I'd be willing to exceed the ask to get into this stock but then again I'm 12 years or so in therefore I'm just a dreamer I guess. I truly can not wrap my mind around how this is playing out. Of course, as I usually say, you folks are way more savvy investors than I am and it would be great to get some perspective from you. If not, no worries and all good!

[Yajne]

...no perspective from me Camphikefish. I am also in a long time, ~ 8 yrs, and I am as puzzled as you

[Rumpl3StiltSkin]

Hey, long time investor here. It is summer. I think once fall comes around then PRs will start up again.

[N0taP00p]

I'm going to go out on a limb and say that a BTD announcement should be coming by the end of this month. That is, if they did submit the application as someone who attended the AGM indicated (was supposed to be days away). 

[skys1]

At the annual meeting the question was asked of Roger, "Is the BTD weeks or months away?" Roger's reply was, "It COULD be days away", not supposed to be days away. There is a big difference.

[DJDawg]

Since we have nothing else to do, I'll speculate. If he said it "could be" then I wonder if that means that they are waiting on an opinion from the FDA consults that they probably hired to review and optimize their chances. who knows

[Longholder99]

Or....they have already sent in the application and are waiting for a response.  

[N0taP00p]

BCG shortage has been going on for 10+ years, driving up the price of alternate drugs significantly.  Here we have a fast-tracked drug that is safer and more potent than keytruda with just 2 treatments 6 months apart. I hope the FDA really steps up here and grant them BTD, AA and an option to add this as an adjuvant treatment under the Frontrunner program. One can dream. For now, I'm

[Infinity]

I happen to hold stocks in CytoDyn Inc. Traded OTC :CYDY  Somewhat similar in terms of an early stage Biotech company.  CEO and their chosen Clinical Research firm Amarex  simply over stated their results.  FDA obviously rejected their claims.  SP took a nose dive!!.   The reason for my comparison is that I am glad tha Dr. Mndel and RDW are way more diligent in